Allergan, Inc.
Allergan signs agreement with U.S. Internal Revenue Service
Published in Lab Business Week, April 9th, 2006
Allergan, Inc., (AGN) announced that on March 1, 2006, after the publication of Allergan's fourth quarter and full year earnings release but before the filing of Allergan's 2005 Form 10-K, Allergan and the United States Internal Revenue Service entered into an agreement resolving certain tax disputes and permitting Allergan to release a valuation allowance taken in the fourth quarter of 2005 and certain tax contingencies established in prior periods.
As a result of the settlement with the Internal Revenue Service and the reversal of these allowances and contingencies, the company's fourth quarter and full year 2005 GAAP diluted earnings per share (EPS) reported in the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2006-04-09)
More Articles from Lab Business Week
- AAIPharma, Inc.
AAIPharma completes financial reorganization - AXM Pharma, Inc.
AXM Pharma awarded $1.2M grant from Chinese government - Able Laboratories, Inc.
Able Laboratories files proposed plan of reorganization - Adolor Corp.
Adolor reports loss of $1.45 per share - Akorn, Inc.
Akorn reports additional $4.3M private placement of common stock - Antares Pharma, Inc.
Antares completes $11.0M private placement - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
